Atlas Trials

A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.

Clinical trial NCT06839131 · RECRUITING

Trial details

NCT number
NCT06839131
Sponsor
Shanghai Pharmaceuticals Holding Co., Ltd
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2025-03-02
Primary completion
2026-12-31
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.